Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Fulcrum Therapeutics, Inc. (FULC) had Income from Continuous Operations of $-17.66M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-17.66M |
|
-- |
|
-- |
|
$20.40M |
|
$-20.40M |
|
$2.75M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
|
Income from Continuous Operations |
$-17.66M |
$-17.66M |
|
$-17.66M |
|
$-20.40M |
|
$-20.05M |
|
62.48M |
|
62.48M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$232.56M |
|
$3.55M |
|
$10.09M |
|
$242.65M |
|
$8.10M |
|
-- |
|
$6.06M |
|
$14.16M |
|
$228.49M |
|
$228.49M |
|
$228.49M |
|
53.98M |
|
| Cash Flow Statement Financials | |
$-15.26M |
|
$-0.78M |
|
-- |
|
$59.41M |
|
$43.38M |
|
$-16.03M |
|
$3.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.73% |
|
-7.73% |
|
-7.28% |
|
-7.73% |
|
$4.23 |
|
$-0.24 |
|
$-0.24 |
|